Bill Sponsor
BILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 7679
117th Congress(2021-2022)
To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the authority to grant certain exemptions, and for other purposes.
Introduced
Introduced
Introduced in House on May 6, 2022
Overview
Text
Introduced in House 
May 6, 2022
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(May 6, 2022)
May 6, 2022
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 7679 (Introduced-in-House)


117th CONGRESS
2d Session
H. R. 7679


To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the authority to grant certain exemptions, and for other purposes.

IN THE HOUSE OF REPRESENTATIVES

May 6, 2022

Mrs. Fletcher (for herself and Mr. Bilirakis) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the authority to grant certain exemptions, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Reauthorizing the humanitarian device exemption profit incentive.

Section 520(m)(6)(A)(iv) of the Federal Food, Drug, and Cosmetic Act (42 U.S.C. 360j(m)(6)(A)(iv)) is amended by striking “2022” and inserting “2027”.

SEC. 2. Reauthorizing the pediatric device consortia program.

Section 305(e) of the Food and Drug Administration Amendments Act of 2007 (42 U.S.C. 282 note) is amended by striking “fiscal years 2018 through 2022” and inserting “fiscal years 2023 through 2027”.